RNA Interference in Mouse Models

Erwei Song,Patrick Stern,Deborah Palliser,Luk Van Parijs,Judy Lieberman
DOI: https://doi.org/10.1201/9780203489253.ch20
2004-01-01
Abstract:Soon after Tuschl and colleagues demonstrated that RNA interference (RNAi) operates in mammalian cells via short RNA duplexes of 19 to 23 nucleotides in length, 1 tremendous efforts were taken to study the feasibility of this new technique to treat human disease. RNAi has been shown to mediate specific and effective gene silencing. The specificity and effectiveness, coupled with the fact that every animal gene can potentially be targeted via this mechanism, suggest that this technique may provide an exciting new therapeutic tool with a wide array of potential disease targets. 2 However, two recent reports suggest that siRNAs, particularly at high concentrations, may also silence genes with incomplete homology and induce an interferon (IFN) response with global inhibition of translation. These off-target effects may lead to toxicity and need to be considered in all in vivo experiments. Induction of an IFN response …
What problem does this paper attempt to address?